161 related articles for article (PubMed ID: 16312631)
21. A Relook of Cefuroxime in Community Infections: An Option Still Beneficial.
Badhwar VR; Ganapathy S; Prabhudesai PP; Tulara NK; Varaiya AY; Vyas D
J Assoc Physicians India; 2016 Jul; 64(7):95-101. PubMed ID: 27759360
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and tolerability of cefuroxime-axetil in infections of the upper respiratory tract. Comparative study with cefadroxil].
Dupuis G; Ebbo D; Evennou A; Pappo M
Rev Laryngol Otol Rhinol (Bord); 1989; 110(1):123-6. PubMed ID: 2491707
[TBL] [Abstract][Full Text] [Related]
23. [Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
Bogdanov MB; Chernen'kaia TV
Antibiot Khimioter; 2000; 45(10):15-8. PubMed ID: 11212394
[TBL] [Abstract][Full Text] [Related]
24. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
Pell DM
Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
[No Abstract] [Full Text] [Related]
25. Clinical and economic outcomes in the treatment of lower respiratory tract infections.
Brixner DI
Am J Manag Care; 2004 Oct; 10(12 Suppl):S400-7. PubMed ID: 15603249
[No Abstract] [Full Text] [Related]
26. An assessment of the clinical efficacy in general practice of cefuroxime axetil when used in the management of unidentified infections of the lower respiratory tract.
Wight LJ; Vandenburg MJ; Griffiths GK; Gudgeon AC; Kelsey M
Br J Clin Pract; 1987 Nov; 41(11):991-4. PubMed ID: 3504320
[No Abstract] [Full Text] [Related]
27. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
28. [Systemic antibiotherapy for the treatment of lower respiratory tract infections. Community acquired pneumonia, acute exacerbation of obstructive chronic bronchitis].
Chidiac C; ;
Med Mal Infect; 2011 May; 41(5):221-8. PubMed ID: 21106313
[No Abstract] [Full Text] [Related]
29. [Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia].
Jiang XT; Du YP; Deng LP
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1876-8. PubMed ID: 15631797
[TBL] [Abstract][Full Text] [Related]
30. The safety, efficacy, and tolerability of cefuroxime axetil suspension in infants and children receiving previous intravenous antibiotic therapy.
Powell DA; Nahata MC; Powell NE; Ossi MJ
DICP; 1991 Nov; 25(11):1236-8. PubMed ID: 1763541
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
Drehobl M; Bianchi P; Keyserling CH; Tack KJ; Griffin TJ
Antimicrob Agents Chemother; 1997 Jul; 41(7):1579-83. PubMed ID: 9210689
[TBL] [Abstract][Full Text] [Related]
32. A dose-ranging study of cefuroxime axetil in the treatment of lower respiratory tract infections in general practice.
Spencer RC; Griggs JV; Brown GW
Drugs Exp Clin Res; 1987; 13(2):101-3. PubMed ID: 3582133
[TBL] [Abstract][Full Text] [Related]
33. [Cefuroxime axetil--efficiency and safety for treatment of upper airways and middle ear infections in children].
Barliński J
Pol Tyg Lek; 1993 Mar 1-8; 48(9-10):233-5. PubMed ID: 8234058
[TBL] [Abstract][Full Text] [Related]
34. [Clinical study of the tolerance of a new antibiotic by a pharmacovigilance cohort. Apropos of cefuroxime-axetil].
Carbon C; Bons J; Georges D
Therapie; 1988; 43 Suppl 4():369-72. PubMed ID: 3222779
[No Abstract] [Full Text] [Related]
35. [Cefuroxime axetil. An antibiotic advances].
Fortschr Med Suppl; 1990; 92():4-13. PubMed ID: 2199359
[No Abstract] [Full Text] [Related]
36. Community-acquired lower respiratory tract infections: etiology and treatment.
Guthrie R
Chest; 2001 Dec; 120(6):2021-34. PubMed ID: 11742937
[TBL] [Abstract][Full Text] [Related]
37. Tissue penetration following orally administered cefuroxime axetil.
Wise R
J Chemother; 1989 Jul; 1(4 Suppl):515-6. PubMed ID: 16312510
[No Abstract] [Full Text] [Related]
38. [Use of cefuroxime axetil in clinical practice].
Słowińska M; Szymańska E; Walecka I; Rudnicka L
Pol Merkur Lekarski; 2000 Nov; 9(53):785-90. PubMed ID: 11204332
[TBL] [Abstract][Full Text] [Related]
39. [15th Consensus Conference on anti-infectious treatments: management of viral infections of the lower respiratory tract in the immunocompetent adult. Short text].
; ; ; ; ; ; ; ;
Rev Pneumol Clin; 2007 Feb; 63(1):7-18. PubMed ID: 17457279
[No Abstract] [Full Text] [Related]
40. [Evaluation of cefuroxime-axetil in the treatment of acute sinusitis in adults. Comparative study with cefaclor].
Freche C; Fombeur JP; Pappo M
Therapie; 1988; 43 Suppl 4():365-8. PubMed ID: 3222778
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
